Greatmark Investment Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.61M Sell
124,861
-1,642
-1% -$113K 1.08% 29
2025
Q1
$8.57M Sell
126,503
-1,760
-1% -$119K 1.17% 28
2024
Q4
$5.76M Sell
128,263
-178,639
-58% -$8.02M 0.78% 36
2024
Q3
$19.3M Buy
306,902
+11,072
+4% +$696K 2.62% 13
2024
Q2
$17.5M Buy
295,830
+22,703
+8% +$1.34M 2.55% 13
2024
Q1
$21.8M Buy
273,127
+11,999
+5% +$957K 3.1% 8
2023
Q4
$20.6M Buy
261,128
+9,868
+4% +$779K 3.23% 9
2023
Q3
$17.5M Buy
251,260
+12,750
+5% +$890K 3.1% 7
2023
Q2
$16.5M Buy
238,510
+24,724
+12% +$1.71M 2.78% 9
2023
Q1
$15.9M Buy
213,786
+5,099
+2% +$379K 2.83% 11
2022
Q4
$19.4M Sell
208,687
-4,984
-2% -$464K 3.56% 7
2022
Q3
$20.4M Buy
213,671
+1,681
+0.8% +$160K 3.93% 6
2022
Q2
$19.6M Buy
211,990
+2,904
+1% +$269K 3.77% 5
2022
Q1
$21.2M Sell
209,086
-915
-0.4% -$92.6K 3.48% 9
2021
Q4
$21.7M Sell
210,001
-149
-0.1% -$15.4K 3.64% 6
2021
Q3
$17.8M Buy
210,150
+2,487
+1% +$211K 3.34% 8
2021
Q2
$17.3M Buy
207,663
+2,416
+1% +$202K 3.13% 9
2021
Q1
$15.4M Sell
205,247
-418
-0.2% -$31.4K 3.02% 9
2020
Q4
$14M Sell
205,665
-1,244
-0.6% -$85K 3.04% 10
2020
Q3
$12.1M Buy
206,909
+6,921
+3% +$404K 3.04% 11
2020
Q2
$13M Sell
199,988
-2,024
-1% -$131K 3.42% 8
2020
Q1
$12M Buy
202,012
+3,145
+2% +$187K 3.85% 5
2019
Q4
$14.8M Buy
198,867
+5,391
+3% +$401K 3.65% 7
2019
Q3
$12.2M Buy
193,476
+9,571
+5% +$604K 3.34% 7
2019
Q2
$10M Buy
183,905
+45,890
+33% +$2.5M 2.99% 10
2019
Q1
$7.44M Buy
138,015
+20,940
+18% +$1.13M 2.35% 14
2018
Q4
$7.67M Buy
117,075
+39,475
+51% +$2.59M 2.75% 12
2018
Q3
$6.11M Buy
77,600
+7,480
+11% +$589K 1.92% 19
2018
Q2
$4.51M Buy
70,120
+42,735
+156% +$2.75M 1.56% 23
2018
Q1
$1.7M Buy
+27,385
New +$1.7M 0.62% 39